<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Anaesthesiol Clin Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">J Anaesthesiol Clin Pharmacol</journal-id><journal-id journal-id-type="publisher-id">JOACP</journal-id><journal-title-group><journal-title>Journal of Anaesthesiology, Clinical Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0970-9185</issn><issn pub-type="epub">2231-2730</issn><publisher><publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22557745</article-id><article-id pub-id-type="pmc">3339727</article-id><article-id pub-id-type="publisher-id">JOACP-28-210</article-id><article-id pub-id-type="doi">10.4103/0970-9185.94877</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Induction for classic laryngeal mask airway insertion: Does low-dose fentanyl work?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dutt</surname><given-names>Akanksha</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Joad</surname><given-names>Anjum Khan</given-names></name><xref ref-type="aff" rid="aff1"></xref><xref ref-type="corresp" rid="cor1"></xref></contrib><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Mamta</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib></contrib-group><aff id="aff1">Department of Anesthesiology, Bhagwan Mahaveer Cancer Hospital and Research Centre, Jaipur, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Anjum S Kahn Joad, Bhagwan Mahaveer Cancer Hospital, JLN Marg, Malviya Nagar, Jaipur, India. E-mail: <email xlink:href="anjumjoad@hotmail.com">anjumjoad@hotmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Apr-Jun</season><year>2012</year></pub-date><volume>28</volume><issue>2</issue><fpage>210</fpage><lpage>213</lpage><permissions><copyright-statement>Copyright: © Journal of Anaesthesiology Clinical Pharmacology</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="2893" xml_f="2904" txt_i="11" txt_f="22">Background:</offsets></title><p><offsets xml_i="2915" xml_f="3126" txt_i="23" txt_f="234">Laryngeal mask airway (LMA) insertion requires an optimal balance of anesthesia. Propofol with different opioids is a preferred combination. Two doses of fentanyl were compared for the efficacy and side effects.</offsets></p></sec><sec id="st2"><title><offsets xml_i="3157" xml_f="3179" txt_i="236" txt_f="258">Materials and Methods:</offsets></title><p><offsets xml_i="3190" xml_f="3234" txt_i="259" txt_f="303">96 patients were randomly distributed into F</offsets><sub><offsets xml_i="3239" xml_f="3240" txt_i="303" txt_f="304">1</offsets></sub><offsets xml_i="3246" xml_f="3272" txt_i="304" txt_f="330"> (fentanyl 1 mcg/kg) and F</offsets><sub><offsets xml_i="3277" xml_f="3278" txt_i="330" txt_f="331">2</offsets></sub><offsets xml_i="3284" xml_f="3431" txt_i="331" txt_f="478"> (fentanyl 2 mcg/kg) groups. The conditions for LMA insertion, hemodynamic profile, bronchoscopic view, and incidence of sore throat were compared.</offsets></p></sec><sec id="st3"><title><offsets xml_i="3462" xml_f="3469" txt_i="480" txt_f="487">Result:</offsets></title><p><offsets xml_i="3480" xml_f="3638" txt_i="488" txt_f="646">There was no statistically significant difference in any parameter in the two groups except for a significant fall in systolic and mean arterial pressure in F</offsets><sub><offsets xml_i="3643" xml_f="3644" txt_i="646" txt_f="647">2</offsets></sub><offsets xml_i="3650" xml_f="3657" txt_i="647" txt_f="654"> group.</offsets></p></sec><sec id="st4"><title><offsets xml_i="3688" xml_f="3699" txt_i="656" txt_f="667">Conclusion:</offsets></title><p><offsets xml_i="3710" xml_f="3869" txt_i="668" txt_f="827">Both doses of fentanyl (1 and 2 mcg/kg) provide comparable insertion conditions for LMA. Fentanyl in the lower dose provides a more stable hemodynamic profile.</offsets></p></sec></abstract><kwd-group><kwd>Bronchoscopic view</kwd><kwd>fentanyl</kwd><kwd>insertion conditions</kwd><kwd>laryngeal mask airway</kwd></kwd-group></article-meta></front><body><sec id="sec1-1"><title><offsets xml_i="4077" xml_f="4089" txt_i="836" txt_f="848">Introduction</offsets></title><p><offsets xml_i="4100" xml_f="4350" txt_i="849" txt_f="1099">Insertion of laryngeal mask airway (LMA) requires sufficient depth of anesthesia for jaw muscles to relax and suppression of airway reflexes for the device to be tolerated within the hypopharynx without undue coughing, gagging, and patient movement.[</offsets><xref ref-type="bibr" rid="ref1"><offsets xml_i="4383" xml_f="4384" txt_i="1099" txt_f="1100">1</offsets></xref><offsets xml_i="4391" xml_f="4642" txt_i="1100" txt_f="1351">] Such conditions are provided by a generous dose of an intravenous (IV) anesthetic induction agent. Propofol itself does not have analgesic activity and when used alone, the high doses required for induction may cause adverse cardiovascular effects.[</offsets><xref ref-type="bibr" rid="ref2"><offsets xml_i="4675" xml_f="4676" txt_i="1351" txt_f="1352">2</offsets></xref><offsets xml_i="4683" xml_f="4961" txt_i="1352" txt_f="1630">] Fentanyl has been reported to provide satisfactory conditions for insertion of LMA without administration of muscle relaxants. We compared insertion conditions for LMA silicone classic using propofol in a fixed dose (2.5 mg/kg) and fentanyl in two doses, i.e., 1 and 2 mcg/kg.</offsets></p></sec><sec sec-type="materials|methods" id="sec1-2"><title><offsets xml_i="5024" xml_f="5045" txt_i="1632" txt_f="1653">Materials and Methods</offsets></title><p><offsets xml_i="5056" xml_f="5615" txt_i="1654" txt_f="2204">After approval from the hospital Research and Ethical Committee, a prospective, randomized double-blind study was conducted on patients of American Society of Anesthesiologists (ASA) grades 1 and 2, between 18 and 60 years of age, undergoing elective surgery (modified radical mastectomy, mastectomy, or superficial surgery of the upper limb). The exclusion criteria were risk of aspiration and regurgitation, mouth opening &lt; 2.5 cm, weight &lt; 40 kg or &gt;110 kg, respiratory tract pathology, cervical spine disease, and an anticipated difficult airway.</offsets></p><p><offsets xml_i="5622" xml_f="5813" txt_i="2205" txt_f="2396">An informed consent was obtained from all patients. Patients were randomly allocated using sealed envelope technique to two groups of 52 each. Fentanyl was used in a dose of 1 mcg/kg in the F</offsets><sub><offsets xml_i="5818" xml_f="5819" txt_i="2396" txt_f="2397">1</offsets></sub><offsets xml_i="5825" xml_f="5853" txt_i="2397" txt_f="2425"> group and 2 mcg/kg in the F</offsets><sub><offsets xml_i="5858" xml_f="5859" txt_i="2425" txt_f="2426">2</offsets></sub><offsets xml_i="5865" xml_f="6105" txt_i="2426" txt_f="2666"> group. All patients were fasted for over 6 h and premedicated with oral diazepam 0.1 mg/kg. Intraoperative monitoring included electrocardiogram, noninvasive blood pressure, oxygen saturation, end-tidal carbon dioxide, and airway pressure.</offsets></p><p><offsets xml_i="6112" xml_f="6446" txt_i="2667" txt_f="3001">Following preoxygenation, ondansetron 0.1 mg/kg IV was given. The study drug, fentanyl 1 or 2 mcg/kg was given IV over 10 s by an anesthesiologist blinded to the drug dose. Two minutes after administration of this, propofol 2.5 mg/kg was injected IV over 1 min. The jaw thrust was used as an indicator of adequate depth of anesthesia.</offsets></p><p><offsets xml_i="6453" xml_f="7017" txt_i="3002" txt_f="3566">In all patients, a classic silicone LMA was inserted by an experienced anesthesiologist using index finger technique. After adequate depth of anesthesia was attained, the patient's head was extended, neck flexed, jaw opened, and the LMA was inserted. The cuff was inflated with air in 3 ml increments until the LMA tube was seen to rise slightly out of patient's mouth. The anesthesiologist was blinded regarding dose of fentanyl. On attempting LMA insertion, if mouth opening was not adequate, further bolus doses of propofol were given in increments of 10 mg IV.</offsets></p><p><offsets xml_i="7024" xml_f="7415" txt_i="3567" txt_f="3958">Time taken from induction and number of attempts taken were noted in both study groups. After three failed attempts, the patient's trachea was intubated. In case LMA insertion took more than 20 s or more than three attempts were required, it was considered as failure and the case was excluded from statistical analysis. The heart rate and blood pressure were recorded by a blinded assessor.</offsets></p><p><offsets xml_i="7422" xml_f="7482" txt_i="3959" txt_f="4019">Optimal ventilation was assessed by the following criteria:[</offsets><xref ref-type="bibr" rid="ref3"><offsets xml_i="7515" xml_f="7516" txt_i="4019" txt_f="4020">3</offsets></xref><offsets xml_i="7523" xml_f="7707" txt_i="4020" txt_f="4204">] adequate chest expansion, square wave capnography, and stable oxygenation. Following successful LMA insertion, position of LMA was assessed using fiberoptic bronchoscope and graded.[</offsets><xref ref-type="bibr" rid="ref4"><offsets xml_i="7740" xml_f="7741" txt_i="4204" txt_f="4205">4</offsets></xref><xref ref-type="bibr" rid="ref5"><offsets xml_i="7781" xml_f="7782" txt_i="4205" txt_f="4206">5</offsets></xref><offsets xml_i="7789" xml_f="7871" txt_i="4206" txt_f="4288">] LMA insertion conditions were graded on a three point scale using six variables[</offsets><xref ref-type="bibr" rid="ref6"><offsets xml_i="7904" xml_f="7905" txt_i="4288" txt_f="4289">6</offsets></xref><offsets xml_i="7912" xml_f="8013" txt_i="4289" txt_f="4390">] – mouth opening, ease of LMA insertion, swallowing, coughing, patient movements, and laryngospasm [</offsets><xref ref-type="table" rid="T1"><offsets xml_i="8045" xml_f="8052" txt_i="4390" txt_f="4397">Table 1</offsets></xref><offsets xml_i="8059" xml_f="8061" txt_i="4397" txt_f="4399">].</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="8109" xml_f="8116" txt_i="4400" txt_f="4407">Table 1</offsets></label><caption><p><offsets xml_i="8136" xml_f="8155" txt_i="4407" txt_f="4426">LMA insertion score</offsets></p></caption><graphic xlink:href="JOACP-28-210-g001"></graphic></table-wrap><p><offsets xml_i="8235" xml_f="8640" txt_i="4427" txt_f="4832">Anesthesia was maintained with isoflurane, nitrous oxide in oxygen, and vecuronium bromide using a standard technique. On completion of the surgery neuromuscular block was antagonized with neostigmine and glycopyrrolate. LMA was removed after deflating the cuff when the patient regained consciousness. Patients were evaluated for sore throat in the immediate postoperative period and for 24 h thereafter.</offsets></p><p><offsets xml_i="8647" xml_f="8852" txt_i="4833" txt_f="5038">In a pilot study, fentanyl 1 mcg/kg with propofol 2.5 mg/kg given 3 min prior to LMA insertion, was found to provide excellent insertion conditions in 80% of patients. Based on this data, a sample size of </offsets><italic><offsets xml_i="8860" xml_f="8861" txt_i="5038" txt_f="5039">n</offsets></italic><offsets xml_i="8870" xml_f="9203" txt_i="5039" txt_f="5372"> = 96 was required to show an improvement of 15% (95%) in LMA insertion success rate with α = 0.05 and a power of 80% with fentanyl in a dose of 2 mcg/kg. Sample size was calculated using Medcalc (Medcalc Software, Mariakerke, Belgium). Statistical analysis was done using chi-square method. Hemodynamic parameters were analyzed by “</offsets><italic><offsets xml_i="9211" xml_f="9212" txt_i="5372" txt_f="5373">t</offsets></italic><offsets xml_i="9221" xml_f="9228" txt_i="5373" txt_f="5380">” test.</offsets></p></sec><sec sec-type="results" id="sec1-3"><title><offsets xml_i="9281" xml_f="9288" txt_i="5382" txt_f="5389">Results</offsets></title><p><offsets xml_i="9299" xml_f="9649" txt_i="5390" txt_f="5740">The patients in both groups were comparable in terms of age, weight, ASA status, and airway (Mallampati grade). Three patients in each group were excluded from analysis as they needed tracheal intubation as LMA insertion took more than 20 s or more than three attempts were required. Overall LMA insertion and fiberoptic score was comparable [Tables </offsets><xref ref-type="table" rid="T2"><offsets xml_i="9681" xml_f="9682" txt_i="5740" txt_f="5741">2</offsets></xref><offsets xml_i="9689" xml_f="9694" txt_i="5741" txt_f="5746"> and </offsets><xref ref-type="table" rid="T3"><offsets xml_i="9726" xml_f="9727" txt_i="5746" txt_f="5747">3</offsets></xref><offsets xml_i="9734" xml_f="9778" txt_i="5747" txt_f="5791">] as was time taken and number of attempts [</offsets><xref ref-type="table" rid="T4"><offsets xml_i="9810" xml_f="9817" txt_i="5791" txt_f="5798">Table 4</offsets></xref><offsets xml_i="9824" xml_f="9826" txt_i="5798" txt_f="5800">].</offsets></p><table-wrap id="T2" position="float"><label><offsets xml_i="9874" xml_f="9881" txt_i="5801" txt_f="5808">Table 2</offsets></label><caption><p><offsets xml_i="9901" xml_f="9920" txt_i="5808" txt_f="5827">LMA insertion score</offsets></p></caption><graphic xlink:href="JOACP-28-210-g002"></graphic></table-wrap><table-wrap id="T3" position="float"><label><offsets xml_i="10041" xml_f="10048" txt_i="5828" txt_f="5835">Table 3</offsets></label><caption><p><offsets xml_i="10068" xml_f="10110" txt_i="5835" txt_f="5877">Fibreoptic scoring of the position of LMA[</offsets><xref ref-type="bibr" rid="ref4"><offsets xml_i="10143" xml_f="10144" txt_i="5877" txt_f="5878">4</offsets></xref><xref ref-type="bibr" rid="ref5"><offsets xml_i="10184" xml_f="10185" txt_i="5878" txt_f="5879">5</offsets></xref><offsets xml_i="10192" xml_f="10193" txt_i="5879" txt_f="5880">]</offsets></p></caption><graphic xlink:href="JOACP-28-210-g003"></graphic></table-wrap><table-wrap id="T4" position="float"><label><offsets xml_i="10314" xml_f="10321" txt_i="5881" txt_f="5888">Table 4</offsets></label><caption><p><offsets xml_i="10341" xml_f="10384" txt_i="5888" txt_f="5931">Time taken and attempts taken to insert LMA</offsets></p></caption><graphic xlink:href="JOACP-28-210-g004"></graphic></table-wrap><p><offsets xml_i="10464" xml_f="10561" txt_i="5932" txt_f="6029">There was a significant (a fall of 20% from baseline value) decrease in systolic blood pressure (</offsets><italic><offsets xml_i="10569" xml_f="10570" txt_i="6029" txt_f="6030">P</offsets></italic><offsets xml_i="10579" xml_f="10682" txt_i="6030" txt_f="6130"> &lt; 0.05) at 1, 2, 3, 4, and 5 min and mean arterial pressure at 2 and 3 min after LMA insertion in F</offsets><sub><offsets xml_i="10687" xml_f="10688" txt_i="6130" txt_f="6131">2</offsets></sub><offsets xml_i="10694" xml_f="10960" txt_i="6131" txt_f="6394">, but this fall in blood pressure was not clinically relevant and did not need any intervention. The heart rate did not show any significant changes in either group though the incidence of bradycardia (heart rate &lt; 60 beats per minute) was higher (16%) in group F</offsets><sub><offsets xml_i="10965" xml_f="10966" txt_i="6394" txt_f="6395">2</offsets></sub><offsets xml_i="10972" xml_f="10992" txt_i="6395" txt_f="6415"> compared to group F</offsets><sub><offsets xml_i="10997" xml_f="10998" txt_i="6415" txt_f="6416">1</offsets></sub><offsets xml_i="11004" xml_f="11177" txt_i="6416" txt_f="6589">. Two of these patients needed atropine IV to reverse bradycardia. Incidence of sore throat was comparable immediately after recovery and 24 h after recovery in both groups.</offsets></p><p><offsets xml_i="11184" xml_f="11695" txt_i="6590" txt_f="7101">The overall conditions for LMA insertion, mean time taken, total number of attempts taken for insertion, fiberoptic view, and incidence of sore throat were comparable in both study groups. There was a significant fall in systolic blood pressures and mean arterial pressure and higher incidence of bradycardia in the group receiving fentanyl 2 mcg/kg. The patients who received fentanyl 1 mcg/kg remained more hemodynamically stable compared to those receiving fentanyl 2 mcg/kg in our cancer patient population.</offsets></p></sec><sec sec-type="discussion" id="sec1-4"><title><offsets xml_i="11751" xml_f="11761" txt_i="7103" txt_f="7113">Discussion</offsets></title><p><offsets xml_i="11772" xml_f="12137" txt_i="7114" txt_f="7479">Induction regime for LMA insertion should provide a depth of anesthesia with a relaxed jaw and suppressed airway reflexes. The optimal insertion conditions for LMA insertion include a relaxed jaw, adequate mouth of opening, and suppressed airway reflexes. This study was designed to compare the insertion conditions when propofol is used with two doses of fentanyl.</offsets></p><p><offsets xml_i="12144" xml_f="12166" txt_i="7480" txt_f="7502">A dose response study[</offsets><xref ref-type="bibr" rid="ref7"><offsets xml_i="12199" xml_f="12200" txt_i="7502" txt_f="7503">7</offsets></xref><offsets xml_i="12207" xml_f="12577" txt_i="7503" txt_f="7873">] conducted to predict an optimal dose of fentanyl (placebo and fentanyl 0.5, 1.0, 1.5, and 2.0 mcg/kg) coadministered with propofol 2.5 mg/kg for inserting the LMA Classic™ laryngeal mask airway,) concluded that a standard fentanyl dose of 1.0 mcg/kg coadministered with propofol 2.5 mg/kg provided optimal conditions in 65% of cases. In our study 32 cases (66.7%) in F</offsets><sub><offsets xml_i="12582" xml_f="12583" txt_i="7873" txt_f="7874">2</offsets></sub><offsets xml_i="12589" xml_f="12619" txt_i="7874" txt_f="7904"> group and 24 cases (50%) in F</offsets><sub><offsets xml_i="12624" xml_f="12625" txt_i="7904" txt_f="7905">1</offsets></sub><offsets xml_i="12631" xml_f="12789" txt_i="7905" txt_f="8063"> group had excellent insertion conditions. Satisfactory insertion conditions were found in 25% cases and 43% cases with fentanyl 2 and 1 mcg/kg, respectively.</offsets></p><p><offsets xml_i="12796" xml_f="12855" txt_i="8064" txt_f="8123">More patients responded adversely to LMA insertion in the F</offsets><sub><offsets xml_i="12860" xml_f="12861" txt_i="8123" txt_f="8124">1</offsets></sub><offsets xml_i="12867" xml_f="13087" txt_i="8124" txt_f="8344"> group but on statistical analysis both groups had comparable results. In this study, four patient responses to LMA insertion were graded. These were swallowing, coughing-gagging, movement (purposeful), and laryngospasm.</offsets></p><p><offsets xml_i="13094" xml_f="13173" txt_i="8345" txt_f="8424">Patient movement was encountered most frequently and was seen in 20% in group F</offsets><sub><offsets xml_i="13178" xml_f="13179" txt_i="8424" txt_f="8425">1</offsets></sub><offsets xml_i="13185" xml_f="13206" txt_i="8425" txt_f="8446"> and 14.5% in group F</offsets><sub><offsets xml_i="13211" xml_f="13212" txt_i="8446" txt_f="8447">2</offsets></sub><offsets xml_i="13218" xml_f="13370" txt_i="8447" txt_f="8599">. This differs from that of a study comparing LMA Classic insertion conditions following coadministration of alfentanil–propofol and fentanyl–propofol,[</offsets><xref ref-type="bibr" rid="ref6"><offsets xml_i="13403" xml_f="13404" txt_i="8599" txt_f="8600">6</offsets></xref><offsets xml_i="13411" xml_f="13670" txt_i="8600" txt_f="8859">] which found swallowing to be the most common patient response to LMA insertion. The incidence of coughing-gagging in our study was low with seven patients (14%) in fentanyl 1 mcg/kg group and four patients (8%) in the second study group developing it. Wong </offsets><italic><offsets xml_i="13678" xml_f="13683" txt_i="8859" txt_f="8864">et al</offsets></italic><offsets xml_i="13692" xml_f="13694" txt_i="8864" txt_f="8866">.[</offsets><xref ref-type="bibr" rid="ref7"><offsets xml_i="13727" xml_f="13728" txt_i="8866" txt_f="8867">7</offsets></xref><offsets xml_i="13735" xml_f="13930" txt_i="8867" txt_f="9062">] found that higher doses of fentanyl were associated with a notable increase in the incidence of coughing and laryngospasm and attributed these episodes to fentanyl rather than to LMA insertion.</offsets></p><p><offsets xml_i="13937" xml_f="14282" txt_i="9063" txt_f="9408">Laryngospasm was not encountered by us in either study group possibly because we ensured adequate depth of anesthesia and obtundation of airway reflexes, by waiting for 3 min after administration of fentanyl, before attempting LMA insertion. We also used the jaw thrust to assess adequate depth of anesthesia before attempting to insert the LMA.</offsets></p><p><offsets xml_i="14289" xml_f="14296" txt_i="9409" txt_f="9416">Kodaka </offsets><italic><offsets xml_i="14304" xml_f="14309" txt_i="9416" txt_f="9421">et al</offsets></italic><offsets xml_i="14318" xml_f="14320" txt_i="9421" txt_f="9423">.[</offsets><xref ref-type="bibr" rid="ref8"><offsets xml_i="14353" xml_f="14354" txt_i="9423" txt_f="9424">8</offsets></xref><offsets xml_i="14361" xml_f="14932" txt_i="9424" txt_f="9995">] studied the effective concentration of propofol for 50% of attempts to secure laryngeal mask insertion (predicted EC50 LMA) using a target-controlled infusion. The predicted EC50 LMA of all fentanyl groups (0.5, 1.0, and 2 mcg/kg) was significantly lower than that of control group, but neither of the fentanyl groups showed a significant difference. Bi-spectral index (BIS) values after fentanyl 1 and 2 mcg/kg were significantly greater than in control and fentanyl 0.5 mcg/kg groups. There were no differences in hemodynamic responses among any groups for any trend.</offsets></p><p><offsets xml_i="14939" xml_f="15058" txt_i="9996" txt_f="10115">We found that with a fixed dose of propofol there was a statistically significant decrease in systolic blood pressure (</offsets><italic><offsets xml_i="15066" xml_f="15067" txt_i="10115" txt_f="10116">P</offsets></italic><offsets xml_i="15076" xml_f="15185" txt_i="10116" txt_f="10222"> &lt; 0.05) at 1, 2, 3, 4, and 5 min and mean arterial pressure at 2 and 3 min after LMA insertion in group F</offsets><sub><offsets xml_i="15190" xml_f="15191" txt_i="10222" txt_f="10223">2</offsets></sub><offsets xml_i="15197" xml_f="15450" txt_i="10223" txt_f="10473">. The fall was however not clinically relevant and no intervention was needed. The heart rate did not show any significant changes in either group even though the incidence of bradycardia (heart rate &lt; 60 beats per minute) was higher (16%) in group F</offsets><sub><offsets xml_i="15455" xml_f="15456" txt_i="10473" txt_f="10474">2</offsets></sub><offsets xml_i="15462" xml_f="15482" txt_i="10474" txt_f="10494"> compared to group F</offsets><sub><offsets xml_i="15487" xml_f="15488" txt_i="10494" txt_f="10495">1</offsets></sub><offsets xml_i="15494" xml_f="15578" txt_i="10495" txt_f="10579">. This difference in the incidence of bradycardia was not statistically significant.</offsets></p><p><offsets xml_i="15585" xml_f="16119" txt_i="10580" txt_f="11114">In patients with poor hemodynamic profiles (e.g., ASA 3 and 4, patients with history of ischemic heart disease, patients with valvular heart disease/using beta blockers), where a tight control of blood pressures and heart rates would be required, the same fall in pressures could become clinically significant. Bradycardia would also have a deleterious effect in such patients. In such cases fentanyl 1 mcg/kg would be a better option, as it would provide optimum LMA insertion conditions along with a more stable hemodynamic profile.</offsets></p><p><offsets xml_i="16126" xml_f="16436" txt_i="11115" txt_f="11425">Our results indicate that as the preadministered dose of fentanyl was increased from 1 to 2 mcg/ kg, the supplementary doses of propofol required for facilitating LMA Classic™ insertion decreased, even though this decrease was not statistically significant. The supplementary dose of propofol needed by group F</offsets><sub><offsets xml_i="16441" xml_f="16442" txt_i="11425" txt_f="11426">1</offsets></sub><offsets xml_i="16448" xml_f="16480" txt_i="11426" txt_f="11458"> was 7.083 + 18.1 mg and group F</offsets><sub><offsets xml_i="16485" xml_f="16486" txt_i="11458" txt_f="11459">2</offsets></sub><offsets xml_i="16492" xml_f="16527" txt_i="11459" txt_f="11494"> it was 5.625 + 15.97 mg. Kodaka's[</offsets><xref ref-type="bibr" rid="ref8"><offsets xml_i="16560" xml_f="16561" txt_i="11494" txt_f="11495">8</offsets></xref><offsets xml_i="16568" xml_f="16612" txt_i="11495" txt_f="11539">] study is in concordance with our findings.</offsets></p><p><offsets xml_i="16619" xml_f="16760" txt_i="11540" txt_f="11681">The fibreoptic view depends on the alignment of LMA bowl and glottis and the extent to which the epiglottis is down folded during insertion.[</offsets><xref ref-type="bibr" rid="ref9"><offsets xml_i="16793" xml_f="16794" txt_i="11681" txt_f="11682">9</offsets></xref><offsets xml_i="16801" xml_f="17016" txt_i="11682" txt_f="11897">] We did not find any statistically significant difference in the fiberoptic view scores in either study group. We had a low rate of immediate postoperative sore throat as compared to Brimacombe and others (0–50%):[</offsets><xref ref-type="bibr" rid="ref9"><offsets xml_i="17049" xml_f="17050" txt_i="11897" txt_f="11898">9</offsets></xref><xref ref-type="bibr" rid="ref10"><offsets xml_i="17091" xml_f="17093" txt_i="11898" txt_f="11900">10</offsets></xref><offsets xml_i="17100" xml_f="17509" txt_i="11900" txt_f="12309">] 33% in fentanyl 1 mcg/kg and 20% in fentanyl 2 mcg/kg group. There was no significant difference in the time taken for LM[A insertion as well as the number of attempts required in both the groups even though the time taken for LMA insertion was 5 s in two patients in the fentanyl 2 mcg/kg group. In majority of patients (about 90% in each group) the time taken for LMA insertion was in the range of 6–10 s.</offsets></p><p><offsets xml_i="17516" xml_f="17654" txt_i="12310" txt_f="12448">We were unable to find any published data, comparing time taken for LMA insertion using two doses of fentanyl. However, in a study by Lee </offsets><italic><offsets xml_i="17662" xml_f="17667" txt_i="12448" txt_f="12453">et al</offsets></italic><offsets xml_i="17676" xml_f="17678" txt_i="12453" txt_f="12455">.[</offsets><xref ref-type="bibr" rid="ref11"><offsets xml_i="17712" xml_f="17714" txt_i="12455" txt_f="12457">11</offsets></xref><offsets xml_i="17721" xml_f="17988" txt_i="12457" txt_f="12724">] on adult patients breathing 8% sevoflurane for induction of anesthesia, pretreatment with low dose fentanyl (1 mcg/kg) and propofol (0.5 mg/kg) was found to significantly decrease the time taken for LMA insertion when compared with induction with sevoflurane alone.</offsets></p><p><offsets xml_i="17995" xml_f="18329" txt_i="12725" txt_f="13059">The combination of propofol and fentanyl facilitated Classic LMA insertion. Optimal conditions for insertion were obtained with both doses of fentanyl, i.e., 1 and 2 mcg/kg, when propofol was used in a dose of 2.5 mg/kg. Fentanyl 1 mcg/kg provided a more stable hemodynamic profile, with fewer episodes of hypotension and bradycardia.</offsets></p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>M</given-names></name><name><surname>Brain</surname><given-names>AIJ</given-names></name></person-group><article-title>Studies on the laryngeal mask: First, learn the art</article-title><source>Anaesthesia</source><year>1991</year><volume>46</volume><fpage>417</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">2035798</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>IN</given-names></name><name><surname>Kenny</surname><given-names>GN</given-names></name></person-group><article-title>Requirements for target-controlled infusion of Propofol to insert the laryngeal mask airway</article-title><source>Anaesthesia</source><year>1998</year><volume>53</volume><fpage>222</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9613265</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shafik</surname><given-names>MT</given-names></name><name><surname>Bahlman</surname><given-names>BU</given-names></name><name><surname>Hall</surname><given-names>JE</given-names></name><name><surname>Ali</surname><given-names>MS</given-names></name></person-group><article-title>A comparison of soft seal disposable and the Classic re-usable laryngeal mark airway</article-title><source>Anaesthesia</source><year>2006</year><volume>61</volume><fpage>178</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">16430570</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Payne</surname><given-names>J</given-names></name></person-group><article-title>The use of the fibreoptic laryngoscope to confirm the positions of LMA</article-title><source>Anaesthesia</source><year>1989</year><volume>44</volume><fpage>865</fpage><pub-id pub-id-type="pmid">2521122</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brimacombe</surname><given-names>I</given-names></name><name><surname>Berry</surname><given-names>A</given-names></name></person-group><article-title>A proposed fibreoptic scoring system to standardize the assessment of LMA position</article-title><source>Anesth Analg</source><year>1993</year><volume>76</volume><fpage>457</fpage><pub-id pub-id-type="pmid">8424538</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>JK</given-names></name><name><surname>Critchley</surname><given-names>LA</given-names></name><name><surname>Karmaker</surname><given-names>MK</given-names></name><name><surname>Lam</surname><given-names>PK</given-names></name></person-group><article-title>Co-administration of alfentanil propofol improve laryngeal mask airway insertion compared to fentanyl-propofol</article-title><source>Can J Anaesth</source><year>2002</year><volume>49</volume><fpage>508</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">11983670</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>CM</given-names></name><name><surname>Critchley</surname><given-names>LA</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name><name><surname>Khaw</surname><given-names>KS</given-names></name><name><surname>Ngan Kee</surname><given-names>WD</given-names></name></person-group><article-title>Fentanyl dose–response curves when inserting the LMA Classic</article-title><source>Anaesthesia</source><year>2007</year><volume>62</volume><fpage>654</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">17567339</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kodaka</surname><given-names>M</given-names></name><name><surname>Okamoto</surname><given-names>Y</given-names></name><name><surname>Handa</surname><given-names>F</given-names></name><name><surname>Kawasaki</surname><given-names>J</given-names></name><name><surname>Miyao</surname><given-names>H</given-names></name></person-group><article-title>Relation between fentanyl dose and predicted EC<sub>50</sub> of Propofol laryngeal mask insertion</article-title><source>Br J Anaesth</source><year>2004</year><volume>92</volume><fpage>238</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">14722176</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keller</surname><given-names>C</given-names></name><name><surname>Puhringer</surname><given-names>F</given-names></name><name><surname>Brimacombe</surname><given-names>JR</given-names></name></person-group><article-title>Influence of cuff volume on oropharyngeal leak pressure and fibreoptic position with the LMA</article-title><source>Br J Anaesth</source><year>1998</year><volume>81</volume><fpage>186</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9813520</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brimacombe</surname><given-names>J</given-names></name><name><surname>Holyoake</surname><given-names>L</given-names></name><name><surname>Keller</surname><given-names>C</given-names></name><name><surname>Barry</surname><given-names>J</given-names></name><name><surname>Mecklem</surname><given-names>D</given-names></name><name><surname>Blinco</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Emergence characteristics and postoperative laryngopharyngeal morbidity with the LMA: A comparison of high versus low initial cuff volume</article-title><source>Anaesthesia</source><year>2000</year><volume>55</volume><fpage>338</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">10781119</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>MP</given-names></name><name><surname>Kua</surname><given-names>JS</given-names></name><name><surname>Chiu</surname><given-names>WK</given-names></name></person-group><article-title>The use of remifentanil to facilitate the insertion of the laryngeal mask airway</article-title><source>Anesth Analg</source><year>2001</year><volume>93</volume><fpage>359</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">11473861</pub-id></element-citation></ref></ref-list></back></article>